Irrational Exuberance

Back in 1996 then Federal Reserve Chairman Alan Greenspan stated; “But how do we know when irrational exuberance has unduly escalated asset values, which then become subject to unexpected and prolonged contractions as they have in Japan over the past decade?”

Looking at the performance of various diabetes device companies we can’t help but wonder if Mr. Greenspan’s comments might not apply today. Look at how some of these stocks are doing on a year to date basis;

Abbott +9.89%

Medtronic +13.41%

Insulet +31.54%

Dexcom +134.21%

Tandem +1,348.79% and no this . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

© 2005 - 2019 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.